Renalytix Market Cap

Renalytix has a market cap or net worth of $25.84 million as of August 15, 2025. Its market cap has decreased by -9.63% in one year.

Market Cap

25.84M

Enterprise Value

24.30M

Revenue

2.89M

Ranking

n/a

PE Ratio

n/a

Stock Price

$0.14

Market Cap Chart

Since November 6, 2018, Renalytix's market cap has decreased from 84.47M to 25.84M, a decrease of -69.41%. That is a compound annual growth rate of -16.03%.

Market Cap History

Date	Market Cap	% Change
Aug 15, 2025	25.84M	-42.03%
Dec 31, 2024	44.57M	125.93%
Dec 29, 2023	19.73M	-69.84%
Dec 30, 2022	65.42M	-89.22%
Dec 31, 2021	607.05M	26.62%
Dec 31, 2020	479.42M	67.37%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Veradigm	798.20M
Tian'an Technology Group	628.15M
Glass House Brands	597.56M
Elite Pharmaceuticals	567.50M
Nika Pharmaceuticals	360.27M
Northwest Biotherapeutics	349.08M
American Oncology Network	337.45M
CytoDyn	325.38M

Market Cap Rankings